University of Kentucky

The Markey Cancer Center is enrolling 500 lung cancer patients from affiliate sites and tracking if MTB-recommended treatments improve their outcomes.

Precision oncology experts and molecular tumor boards are helping community oncologists decipher NGS reports, reduce reimbursement headaches, and improve patients' outcomes.